+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Hybrid Imaging Market (2019-2025)

  • PDF Icon

    Report

  • 111 Pages
  • January 2020
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 4987635
The Asia Pacific Hybrid Imaging Market is expected to witness market growth of 5.83% CAGR during the forecast period (2019-2025).

Countries in Asia are also projected to see development in the next few years due to an increase in understanding of the early diagnosis of life-threatening diseases and developments in nuclear medicine. Market players are active in the production of advanced software for multimodal imaging devices in the region. For example, syngo.via by Siemens Healthineers integrates different technologies such as Pre-fetching, ALPHA Technology, SMART Layout and Findings Navigator that help to convert data collected by various multimodality imaging instruments such as PET/CT and SPECT/CT into descriptive reports.

The considerable importance of a combined analysis of anatomic and molecular data to diagnose diseases is a key driver of the global market for hybrid imaging systems. In addition to the advantages of hybrid imaging and its growing use in diagnostics, there is a significant opportunity for combination hybrid imaging PET or SPECT with MRI. Increased prevalence of chronic diseases, raised awareness of early diagnosis, and a higher number of diagnostic procedures are driving the market. Accreditation of the site, technologist training, medical training and high processing costs among the underprivileged are the major constraints of the market for hybrid imaging systems. Several hospitals, research centers, and research institutes are extensively installing hybrid imaging systems to determine their potential for various applications. It is a move that has sustained the steady growth of the market in recent years.

Based on Application, the market is segmented into Oncology, Ophthalmology, Cardiology, Brain & Neurology, and Other Applications. Based on Type, the market is segmented into PET/CT systems, SPET/CT systems, PET/MR systems, OCT/Fundus Imaging System and Other types. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers and Other End Use. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC.

Scope of the Study

Market Segmentation:

By Application
  • Oncology
  • Ophthalmology
  • Cardiology
  • Brain & Neurology
  • Other Applications

By Type
  • PET/CT systems
  • SPET/CT systems
  • PET/MR systems
  • OCT/Fundus Imaging System
  • Other types

By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Use

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Siemens AG (Siemens Healthineers)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • General Electric (GE) Co. (GE Healthcare)
  • Hitachi, Ltd. (Hitachi Healthcare)
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Atlantis Worldwide, LLC
  • Cubersa, Inc.
  • Amber Diagnostics, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Hybrid Imaging Market, by Application
1.4.2 Asia Pacific Hybrid Imaging Market, by Type
1.4.3 Asia Pacific Hybrid Imaging Market, by End User
1.4.4 Asia Pacific Hybrid Imaging Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019-Dec - 2015-Jan) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2019-Dec - 2015-Jun) Leading Players
Chapter 4. Asia Pacific Hybrid Imaging Market by Application
4.1 Asia Pacific Oncology Market by Country
4.2 Asia Pacific Ophthalmology Market by Country
4.3 Asia Pacific Cardiology Market by Country
4.4 Asia Pacific Brain & Neurology Market by Country
4.5 Asia Pacific Other Applications Market by Country
Chapter 5. Asia Pacific Hybrid Imaging Market by Type
5.1 Asia Pacific PET/CT systems Market by Country
5.2 Asia Pacific SPET/CT systems Market by Country
5.3 Asia Pacific PET/MR systems Market by Country
5.4 Asia Pacific OCT/Fundus Imaging System Market by Country
5.5 Asia Pacific Other Types Market by Country
Chapter 6. Asia Pacific Hybrid Imaging Market by End Use
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Diagnostic Imaging Centers Market by Country
6.3 Asia Pacific Other End Use Market by Country
Chapter 7. Asia Pacific Hybrid Imaging Market by Country
7.1 China Hybrid Imaging Market
7.1.1 China Hybrid Imaging Market by Application
7.1.2 China Hybrid Imaging Market by Type
7.1.3 China Hybrid Imaging Market by End Use
7.2 Japan Hybrid Imaging Market
7.2.1 Japan Hybrid Imaging Market by Application
7.2.2 Japan Hybrid Imaging Market by Type
7.2.3 Japan Hybrid Imaging Market by End Use
7.3 India Hybrid Imaging Market
7.3.1 India Hybrid Imaging Market by Application
7.3.2 India Hybrid Imaging Market by Type
7.3.3 India Hybrid Imaging Market by End Use
7.4 South Korea Hybrid Imaging Market
7.4.1 South Korea Hybrid Imaging Market by Application
7.4.2 South Korea Hybrid Imaging Market by Type
7.4.3 South Korea Hybrid Imaging Market by End Use
7.5 Singapore Hybrid Imaging Market
7.5.1 Singapore Hybrid Imaging Market by Application
7.5.2 Singapore Hybrid Imaging Market by Type
7.5.3 Singapore Hybrid Imaging Market by End Use
7.6 Malaysia Hybrid Imaging Market
7.6.1 Malaysia Hybrid Imaging Market by Application
7.6.2 Malaysia Hybrid Imaging Market by Type
7.6.3 Malaysia Hybrid Imaging Market by End Use
7.7 Rest of Asia Pacific Hybrid Imaging Market
7.7.1 Rest of Asia Pacific Hybrid Imaging Market by Application
7.7.2 Rest of Asia Pacific Hybrid Imaging Market by Type
7.7.3 Rest of Asia Pacific Hybrid Imaging Market by End Use
Chapter 8. Company Profiles
8.1 Siemens AG (Siemens Healthineers)
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.1.5 SWOT Analysis
8.2 Canon, Inc. (Canon Medical Systems Corporation)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Hitachi, Ltd. (Hitachi Healthcare)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Koninklijke Philips N.V.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 PerkinElmer, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expense
8.7 Bruker Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisition and Mergers:
8.8 Atlantis Worldwide, LLC
8.8.1 Company Overview
8.9 Cubersa, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Product Launches and Product Expansions:
8.1 Amber Diagnostics, Inc.
8.10.1 Company Overview

Companies Mentioned

  • Siemens AG (Siemens Healthineers)
  • Canon, Inc. (Canon Medical Systems Corporation)
  • General Electric (GE) Co. (GE Healthcare)
  • Hitachi, Ltd. (Hitachi Healthcare)
  • Koninklijke Philips N.V.
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Atlantis Worldwide, LLC
  • Cubersa, Inc.
  • Amber Diagnostics, Inc.

Methodology

Loading
LOADING...